MainStreet Bancshares, Inc. (NASDAQ:MNSBP – Get Free Report) was the target of a large decline in short interest in the month of November. As of November 30th, there was short interest totalling 4,100 shares, a decline of 24.1% from the November 15th total of 5,400 shares. Based on an average daily volume of 3,000 shares, the short-interest ratio is currently 1.4 days.
MainStreet Bancshares Price Performance
MNSBP traded down $0.32 during mid-day trading on Friday, reaching $23.90. 1,013 shares of the company traded hands, compared to its average volume of 2,944. MainStreet Bancshares has a 52-week low of $21.05 and a 52-week high of $25.03. The company’s fifty day moving average price is $24.08 and its 200-day moving average price is $23.07.
MainStreet Bancshares Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Monday, December 30th. Shareholders of record on Friday, December 13th will be given a $0.4688 dividend. The ex-dividend date of this dividend is Friday, December 13th. This represents a $1.88 annualized dividend and a yield of 7.85%.
MainStreet Bancshares Company Profile
MainStreet Bancshares, Inc operates as the bank holding company for MainStreet Bank that provides various banking products and services for individuals, small to medium-sized businesses, and professional service organizations. The company offers demand, NOW, money market, savings, and sweep accounts, as well as certificates of deposit; business and consumer checking, interest-bearing checking, business account analysis, and other depository services; and cash management, wire transfer, check imaging, bill pay, remote deposit capture, and courier services.
Featured Articles
- Five stocks we like better than MainStreet Bancshares
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- Why Hershey Stock Has More Room to Run Despite Takeover Rejection
- Ride Out The Recession With These Dividend KingsĀ
- Texas Instruments: The Old-School Tech Titan Still Delivering
- Retail Stocks Investing, Explained
- GRAIL: Biotech Stock Targeting $100B Cancer Market
Receive News & Ratings for MainStreet Bancshares Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MainStreet Bancshares and related companies with MarketBeat.com's FREE daily email newsletter.